DK0833649T4 - Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier - Google Patents

Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier

Info

Publication number
DK0833649T4
DK0833649T4 DK96918707T DK96918707T DK0833649T4 DK 0833649 T4 DK0833649 T4 DK 0833649T4 DK 96918707 T DK96918707 T DK 96918707T DK 96918707 T DK96918707 T DK 96918707T DK 0833649 T4 DK0833649 T4 DK 0833649T4
Authority
DK
Denmark
Prior art keywords
allergies
preparations
prevention
treatment
protein hydrolyzate
Prior art date
Application number
DK96918707T
Other languages
English (en)
Other versions
DK0833649T3 (da
Inventor
Erika Isolauri
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Leena Metsaeniitty
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0833649(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Application granted granted Critical
Publication of DK0833649T3 publication Critical patent/DK0833649T3/da
Publication of DK0833649T4 publication Critical patent/DK0833649T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96918707T 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier DK0833649T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies

Publications (2)

Publication Number Publication Date
DK0833649T3 DK0833649T3 (da) 2003-04-07
DK0833649T4 true DK0833649T4 (da) 2009-07-20

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918707T DK0833649T4 (da) 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier

Country Status (26)

Country Link
US (2) US6506380B1 (da)
EP (1) EP0833649B2 (da)
JP (1) JP3983804B2 (da)
KR (1) KR100494741B1 (da)
CN (1) CN1154506C (da)
AR (1) AR003960A1 (da)
AT (1) ATE230606T1 (da)
BG (1) BG63153B1 (da)
BR (1) BR9607827A (da)
CA (1) CA2224320C (da)
CZ (1) CZ291904B6 (da)
DE (1) DE69625690T3 (da)
DK (1) DK0833649T4 (da)
EE (1) EE03424B1 (da)
ES (1) ES2191103T5 (da)
FI (1) FI104465B (da)
IL (1) IL122577A0 (da)
MX (1) MX9710109A (da)
MY (1) MY113912A (da)
NO (1) NO321504B1 (da)
NZ (1) NZ310478A (da)
PL (1) PL185123B1 (da)
RO (1) RO120243B1 (da)
SK (1) SK284245B6 (da)
WO (1) WO1997000078A1 (da)
ZA (1) ZA965088B (da)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
DK0986314T3 (da) * 1997-06-03 2009-01-19 Ganeden Biotech Inc Probiotisk mælkesyrebakterie til behandling af bakterielle infektioner associeret med SIDS
WO2000042560A2 (en) 1999-01-19 2000-07-20 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides
EP1206523B1 (en) 1999-08-05 2009-03-11 Société des Produits Nestlé S.A. Bifidobacteria preventing diarrhea caused by pathogenic bacteria
CN1198631C (zh) 1999-08-05 2005-04-27 雀巢制品公司 双歧杆菌在制备预防腹泻药物中的用途
WO2001057534A2 (en) * 2000-02-04 2001-08-09 Bioseek Compositions and methods for reducing autoimmunity
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
AU2002220561B2 (en) * 2000-09-25 2007-01-11 Societe Des Produits Nestle S.A. Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
WO2002028402A1 (en) * 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
CN1638650A (zh) * 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
AU2003236689A1 (en) 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
DE60322570D1 (de) 2002-06-28 2008-09-11 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
HUE028143T2 (en) 2004-02-25 2016-12-28 Pioneer Hi Bred Int New crystalline bacillus thuringiensis polypeptides, polynucleotides, and compositions thereof
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
CN101193559A (zh) 2005-04-13 2008-06-04 雀巢技术公司 具有益生菌的婴儿配方食品
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
JP2009515929A (ja) * 2005-11-14 2009-04-16 ネステク ソシエテ アノニム 糖化タンパク質を用いた経口免疫寛容促進
AU2007216461B2 (en) 2006-02-15 2012-08-30 Société des Produits Nestlé S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
PT2031986E (pt) * 2006-06-15 2013-04-19 Nestec Sa Indução de tolerância a proteínas do ovo
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2195443B1 (en) 2007-08-24 2015-01-07 Codexis, Inc. Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PT2244593E (pt) 2008-01-24 2015-08-26 Nestec Sa Cápsula contendo ingredientes nutricionais e método de distribuição de um líquido nutricional a partir da cápsula
HUE029000T2 (en) 2008-02-01 2017-02-28 Murdoch Childrens Res Inst A method of inducing tolerance to an allergen
PT2265135T (pt) 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
EP2285958B1 (en) 2008-06-13 2016-03-09 Codexis, Inc. Method of synthesizing polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
CA2728226A1 (en) 2008-06-24 2010-01-21 Codexis, Inc. Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
RU2392001C2 (ru) * 2008-08-04 2010-06-20 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ лечения желтушных форм вирусного гепатита а у детей с пищевой аллергией
ES2560459T3 (es) 2008-08-27 2016-02-19 Codexis, Inc. Polipéptidos cetorreductasa para la producción de una 3-aril-3-hidroxipropanamina a partir de una 3-aril-3-cetopropanamina
ES2840000T3 (es) 2009-01-08 2021-07-06 Codexis Inc Polipéptidos de transaminasa
CA2754580C (en) 2009-03-17 2014-06-17 Codexis, Inc. Variant endoglucanases and related polynucleotides
WO2010120557A1 (en) 2009-03-31 2010-10-21 Codexis, Inc. Improved endoglucanases
EP2443139B1 (en) 2009-06-16 2016-08-10 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
DK2446025T3 (da) 2009-06-22 2018-10-22 Codexis Inc : ketoreduktase-medieret stereoselektiv vej til alfa-chloralkoholer
US8614081B2 (en) 2009-07-23 2013-12-24 Codexis, Inc. Nitrilase biocatalysts
PT2467032T (pt) * 2009-08-18 2018-04-04 Nestec Sa Composição nutricional compreendendo estirpes de bifidobacterium longum e que reduz os sintomas de alergia alimentar, especialmente em lactentes e crianças
BR112012003706A2 (pt) * 2009-08-18 2015-09-01 Nestec Sa Composição nutritiva que compreende cepas de lactococcus e reduz sintomas de alergia, especialmente em bebês e crianças
WO2011022548A2 (en) 2009-08-19 2011-02-24 Codexis, Inc. Ketoreductase polypeptides for the preparation of phenylephrine
EP2473604B1 (en) 2009-09-04 2017-01-11 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
EP2478137B1 (en) 2009-09-18 2017-09-13 Codexis, Inc. Reduced codon mutagenesis
CN102740868B (zh) 2009-11-25 2016-01-20 科德克希思公司 用于从纤维素生物质产生可溶性糖的重组β-葡糖苷酶变体
EP2504431A4 (en) 2009-11-25 2013-10-16 Codexis Inc RECOMBINANT BETA-GLUCOSIDASE VARIANTS OF THERMOASCUS AURIENTIACUS FOR THE PRODUCTION OF FERMENTABLE SUGARS FROM CELLULOSIC BIOMASS
WO2011071982A2 (en) 2009-12-08 2011-06-16 Codexis, Inc. Synthesis of prazole compounds
CA2783768A1 (en) 2009-12-08 2011-06-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
CA2786001A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
EP2566497B1 (en) 2010-05-04 2015-07-29 Codexis, Inc. Biocatalysts for ezetimibe synthesis
US20120135912A1 (en) 2010-05-10 2012-05-31 Perseid Therapeutics Llc Polypeptide inhibitors of vla4
WO2011150313A1 (en) 2010-05-28 2011-12-01 Codexis, Inc. Pentose fermentation by a recombinant microorganism
US8852900B2 (en) 2010-06-17 2014-10-07 Codexis, Inc. Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol
EP2585587B1 (en) 2010-06-28 2017-08-09 Codexis, Inc. Fatty alcohol forming acyl reductases (fars) and methods of use thereof
AU2011272878B2 (en) 2010-06-30 2015-04-23 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
EP2605772B1 (en) 2010-08-16 2016-06-22 Cardiome International AG Process for preparing aminocyclohexyl ether compounds
CN103080306B (zh) 2010-08-20 2015-02-18 科德克希思公司 糖苷水解酶61家族蛋白在纤维素加工中的用途
HUE037616T2 (hu) 2010-12-08 2018-09-28 Codexis Inc Biokatalizátorok és eljárások armodafinil szintéziséhez
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2691517A4 (en) 2011-03-30 2015-04-22 Codexis Inc FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
BR112013033614A2 (pt) 2011-06-30 2018-05-29 Codexis Inc fermentação de pentose por microorganismo recombinante
DK2748317T3 (da) 2011-08-22 2017-07-17 Codexis Inc GH61-glycosidhydrolase-proteinvarianter og cofaktorer der forstærker GH61-aktivitet
US9109209B2 (en) 2011-09-08 2015-08-18 Codexis, Inc. Biocatalysts and methods for the synthesis of substituted lactams
US20130084608A1 (en) 2011-09-30 2013-04-04 Codexis, Inc. Fungal proteases
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
EP2780448B1 (en) 2011-11-18 2019-09-11 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
EP2794871A4 (en) 2011-12-20 2015-12-30 Codexis Inc VARIANTS OF ENDOGLUCANASE-1B (EG1B)
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9139821B2 (en) 2012-03-23 2015-09-22 Codexis, Inc. Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
HUE042605T2 (hu) 2012-05-08 2019-07-29 Codexis Inc Biokatalizátorok és kémiai vegyületek hidroxilálására szolgáló eljárások
SG11201407297VA (en) 2012-05-11 2014-12-30 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
DK2859099T3 (da) 2012-06-11 2019-07-29 Codexis Inc Svampe-beta-xylosidase-varianter
EP2922953A4 (en) 2012-11-20 2016-11-09 Shell Int Research PENTOSEFERMENTATION BY A RECOMBINANT MICROORGANISM
DK2928865T3 (da) 2012-12-07 2018-06-18 Merck Sharp & Dohme Biokatalytisk transamineringsfremgangsmåde
CA2895752C (en) 2012-12-21 2021-09-21 Codexis, Inc. Engineered biocatalysts and methods for synthesizing chiral amines
SG11201505329YA (en) 2013-01-18 2015-08-28 Codexis Inc Engineered biocatalysts useful for carbapenem synthesis
HUE042206T2 (hu) 2013-02-28 2019-06-28 Codexis Inc Módosított transzamináz polipeptidek ipari biokatalízishez
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
SMT201900315T1 (it) 2013-04-18 2019-07-11 Codexis Inc Polipeptidi di fenilalanina ammoniaca liasi ingegnerizzati
EP3068793B1 (en) 2013-11-13 2021-02-17 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
CA2943432A1 (en) 2014-04-16 2015-10-22 Codexis, Inc. Engineered tyrosine ammonia lyase
WO2016007623A1 (en) 2014-07-09 2016-01-14 Codexis, Inc. Novel p450-bm3 variants with improved activity
SG10202012428PA (en) 2014-11-25 2021-01-28 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US20170360900A1 (en) 2014-12-22 2017-12-21 Codexis, Inc. Human alpha-galactosidase variants
ES2830725T3 (es) 2015-02-10 2021-06-04 Codexis Inc Polipéptidos cetoreductasa para la síntesis de compuestos quirales
JP6755886B2 (ja) 2015-05-07 2020-09-16 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ
US9683220B2 (en) 2015-07-07 2017-06-20 Codexis, Inc. P450-BM3 variants with improved activity
WO2017193022A1 (en) 2016-05-05 2017-11-09 Codexis, Inc. Penicillin-g acylases
WO2017213758A1 (en) 2016-06-09 2017-12-14 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
US11299723B2 (en) 2016-06-15 2022-04-12 Codexis, Inc. Engineered beta-glucosidases and glucosylation methods
SG10202111589RA (en) 2016-08-26 2021-11-29 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
CA3048475A1 (en) 2017-01-05 2018-07-12 Codexis, Inc. Penicillin-g acylases
EP3878967A3 (en) 2017-02-03 2021-12-08 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
SG11201906880VA (en) 2017-02-13 2019-08-27 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
CN110753684A (zh) 2017-04-24 2020-02-04 特沙诺有限公司 尼拉帕利的制造方法
US11021729B2 (en) 2017-04-27 2021-06-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
CA3062550A1 (en) 2017-05-08 2018-11-15 Codexis, Inc. Engineered ligase variants
CA3064574A1 (en) 2017-06-14 2018-12-20 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN117737045A (zh) 2017-06-27 2024-03-22 科德克希思公司 青霉素g酰化酶
WO2019005540A1 (en) 2017-06-30 2019-01-03 Codexis, Inc. T7 POLYMERASE RNA VARIANTS
CN111417724A (zh) 2017-06-30 2020-07-14 科德克希思公司 T7 rna聚合酶变体
CA3080512A1 (en) 2017-11-07 2019-05-16 Codexis, Inc. Transglutaminase variants
MX2020006222A (es) 2017-12-13 2020-08-31 Codexis Inc Polipeptidos de carboxiesterasa para acoplamiento de amidas.
ES3018269T3 (en) 2017-12-13 2025-05-14 Glaxosmithkline Ip Dev Ltd Carboxyesterase biocatalysts
EP3807409A4 (en) 2018-06-12 2022-08-03 Codexis, Inc. Engineered tyrosine ammonia lyase
WO2020014048A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered deoxyribose-phosphate aldolases
MX2021000328A (es) 2018-07-09 2021-03-25 Codexis Inc Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
WO2020014050A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered pantothenate kinase variant enzymes
CA3108728A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered phosphopentomutase variant enzymes
AU2019302423B2 (en) 2018-07-09 2024-11-21 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
JP2021531749A (ja) 2018-07-12 2021-11-25 コデクシス， インコーポレイテッド 操作されたフェニルアラニンアンモニアリアーゼポリペプチド
CA3108268A1 (en) 2018-07-30 2020-02-06 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
CN113316635A (zh) 2018-10-29 2021-08-27 科德克希思公司 工程化dna聚合酶变体
EP3893860A4 (en) 2018-12-14 2023-03-29 Codexis, Inc. ENGINEERED TYROSINE AMMONIA LYASE
MX2021007552A (es) 2018-12-20 2021-08-11 Codexis Inc Variantes de alfa-galactosidasa humana.
WO2020150125A1 (en) 2019-01-15 2020-07-23 Codexis, Inc. Engineered transaminase polypeptides
JP7677630B2 (ja) 2019-05-01 2025-05-15 コデクシス， インコーポレイテッド 操作されたグルコースデヒドロゲナーゼ、ならびにケトンおよびアミン化合物の還元的アミノ化を行うための方法
SG11202110852RA (en) 2019-05-01 2021-10-28 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
AU2020299358A1 (en) 2019-07-02 2021-12-23 Codexis, Inc. Engineered acetate kinase variant enzymes
JP7678580B2 (ja) 2019-07-02 2025-05-16 コデクシス， インコーポレイテッド 操作されたスクロースホスホリラーゼバリアント酵素
WO2021013862A1 (en) 2019-07-23 2021-01-28 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.
CN114760980B (zh) 2019-09-12 2024-10-18 科德克希思公司 针对10-乙酰基-3,7-二羟基吩噁嗪的过氧化物酶活性
US20220372542A1 (en) 2019-10-02 2022-11-24 Abbott Diabetes Care Inc. Detection of analytes by protein switches
WO2021108209A1 (en) 2019-11-26 2021-06-03 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
PE20221266A1 (es) 2019-12-20 2022-08-16 Codexis Inc Variantes de alfa-glucosidasa acida disenadas por ingenieria
BR112022015139A2 (pt) 2020-02-04 2022-10-11 Codexis Inc Polipeptídeo da leucina descarboxilase engenheirada, composição, sequência de polinucleotídeo engenheirado, vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo da leucina descarboxilase engenheirada e para tratar e/ou prevenir os sintomas de doença da urina de xarope de bordo, composição, e, uso
CN115427557A (zh) 2020-04-10 2022-12-02 科德克希思公司 工程化转氨酶多肽
US12612605B2 (en) 2020-04-10 2026-04-28 Codexis, Inc. Carboxyesterase polypeptides for kinetic resolution
WO2022047264A1 (en) 2020-08-28 2022-03-03 Codexis, Inc. Engineered amylase variants
CA3191867A1 (en) 2020-08-28 2022-03-03 Codexis, Inc. Engineered protease variants
CA3201757A1 (en) 2020-12-11 2022-06-16 Mathias Schuetz Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
WO2022133289A2 (en) 2020-12-18 2022-06-23 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
CA3214975A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered cyclic gmp-amp synthase (cgas) variant enzymes
CA3214973A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered guanylate kinase variant enzymes
CA3215105A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered acetate kinase variant enzymes
CN117120600A (zh) 2021-04-02 2023-11-24 科德克希思公司 工程化腺苷酸激酶变体酶
AU2022279241A1 (en) 2021-05-21 2023-11-30 Syntis Bio, Inc. Engineered methionine gamma lyase variants
EP4377451A2 (en) 2021-07-30 2024-06-05 Willow Biosciences, Inc. Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
EP4388088A1 (en) 2021-08-19 2024-06-26 Willow Biosciences, Inc. Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023069865A1 (en) 2021-10-15 2023-04-27 Codexis, Inc. Engineered terminal deoxynucleotidyl transferase variants
EP4416278A4 (en) 2021-10-15 2026-01-14 Codexis Inc MODIFIED DNA POLYMERASE VARIANTS
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
JP2024540358A (ja) 2021-11-01 2024-10-31 シンティス バイオ，インコーポレイティド 工学操作ロイシン脱炭酸酵素
DE112023000593T5 (de) 2022-03-31 2024-11-14 Qingdao Kingagroot Chemical Compound Co., Ltd. Monoaminoxidase und deren anwendung
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
JP2026504068A (ja) 2023-01-12 2026-02-03 ノバルティス アーゲー 改変ケトレダクターゼポリペプチド
WO2025061911A1 (en) 2023-09-22 2025-03-27 Glaxosmithkline Intellectual Property Development Limited Methods of producing nucleotide triphosphates (ntps)
WO2025144700A1 (en) 2023-12-27 2025-07-03 Absci Corporation Nanobody library screening using bacterial surface display
WO2025235589A1 (en) 2024-05-08 2025-11-13 Codexis, Inc. Dna polymerase variants
WO2025242702A1 (en) 2024-05-23 2025-11-27 Glaxosmithkline Intellectual Property Development Limited Enzymatic process for producing n-acetyl galactosamine clusters
CN121450551A (zh) * 2026-01-07 2026-02-03 善恩康生物科技（苏州）有限公司 具有抗炎活性的沙棘源益生菌及其在肠炎治疗中的应用和产品

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ATE113441T1 (de) † 1989-10-02 1994-11-15 Sandoz Nutrition Ltd Proteinhydrolysaten.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
WO1995014485A1 (en) 1993-11-23 1995-06-01 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
EP0833649B1 (en) 2003-01-08
ES2191103T3 (es) 2003-09-01
CN1187772A (zh) 1998-07-15
DE69625690T2 (de) 2003-11-06
EE9700339A (et) 1998-06-15
CA2224320C (en) 2012-03-20
HK1010081A1 (en) 1999-06-11
US6506380B1 (en) 2003-01-14
AU6127896A (en) 1997-01-15
KR100494741B1 (ko) 2005-09-30
NO321504B1 (no) 2006-05-15
ZA965088B (en) 1997-01-22
US20030113340A1 (en) 2003-06-19
US7172756B2 (en) 2007-02-06
KR19990022914A (ko) 1999-03-25
EE03424B1 (et) 2001-06-15
MY113912A (en) 2002-06-29
SK284245B6 (sk) 2004-12-01
SK171597A3 (en) 1998-11-04
ATE230606T1 (de) 2003-01-15
PL185123B1 (pl) 2003-02-28
JPH11510791A (ja) 1999-09-21
EP0833649A1 (en) 1998-04-08
EP0833649B2 (en) 2009-06-03
CA2224320A1 (en) 1997-01-03
CZ399797A3 (cs) 1998-06-17
BR9607827A (pt) 1999-11-30
FI952926L (fi) 1996-12-15
RO120243B1 (ro) 2005-11-30
NO975832L (no) 1997-12-11
FI104465B (fi) 2000-02-15
DE69625690D1 (de) 2003-02-13
FI952926A0 (fi) 1995-06-14
DE69625690T3 (de) 2009-12-24
BG102144A (en) 1998-12-30
AU710126B2 (en) 1999-09-16
AR003960A1 (es) 1998-09-30
ES2191103T5 (es) 2009-11-03
IL122577A0 (en) 1998-06-15
DK0833649T3 (da) 2003-04-07
CN1154506C (zh) 2004-06-23
NO975832D0 (no) 1997-12-11
BG63153B1 (bg) 2001-05-31
WO1997000078A1 (en) 1997-01-03
JP3983804B2 (ja) 2007-09-26
MX9710109A (es) 1998-10-31
CZ291904B6 (cs) 2003-06-18
PL324010A1 (en) 1998-04-27
NZ310478A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
FI974429L (fi) Suspendoituja peptidi/proteiinivalmisteita
DE69422575D1 (de) System zur Erklärung von Austellungsstücken
DK1005475T3 (da) Fremgangsmåde til fremstilling af Glufosinat samt mellemprodukter dertil
BR9607669A (pt) Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo
NO20001240D0 (no) Kay-A immunsystemprotein
FI961037A7 (fi) Valmisteet osteogenisten proteiinien antamiseksi
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
IS4343A (is) Einstofna offitu (Ob) prótín
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
NO963049D0 (no) Modulatorer av forankrende proteinfunksjon
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
DE69534325D1 (de) Peptide zur behandlung von krebs
DK0840548T3 (da) Synergistisk, herbicid sammensætning samt fremgangsmåde til fremstilling deraf
FI963334A7 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
ATE283706T1 (de) ßGEGEN RACEMISIERUNG STABILISIERTE PHARMAZEUTISCHE ZUBEREITUNGEN VON CILANSETRONß
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK0918521T3 (da) Formulering til behandling og/eller forebyggelse af demens
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
ITBZ950045A0 (it) Gioiello e procedimento per la realizzazione dello stesso.
DK0821697T3 (da) Fremgangsmåde til fremstilling af streptograminer
DE69420044D1 (de) Blutregulierende peptide